0001179110-19-004864.txt : 20190409
0001179110-19-004864.hdr.sgml : 20190409
20190409161304
ACCESSION NUMBER: 0001179110-19-004864
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190405
FILED AS OF DATE: 20190409
DATE AS OF CHANGE: 20190409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCCLENNEN PETER A
CENTRAL INDEX KEY: 0001322295
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 19739600
MAIL ADDRESS:
STREET 1: C/O TELADOC, INC.
STREET 2: 2 MANHATTANVILLE ROAD, SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER NAME:
FORMER CONFORMED NAME: McClennen Peter
DATE OF NAME CHANGE: 20050330
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
edgar.xml
FORM 4 -
X0306
4
2019-04-05
0
0001477449
Teladoc Health, Inc.
TDOC
0001322295
MCCLENNEN PETER A
C/O TELADOC HEALTH, INC.
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
0
1
0
0
President
Common Stock
2019-04-05
4
M
0
13063
32.50
A
22733
D
Common Stock
2019-04-05
4
S
0
13063
57.14
D
9670
D
Employee Stock Option (right to buy)
32.50
2019-04-05
4
M
0
13063
0.00
D
2027-11-03
Common Stock
13063
156533
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 4, 2019.
Represents the weighted average price of transactions ranging from $56.90 to $57.35. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
The option vested as to 25% of the shares on November 3, 2018. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter.
/s/ Adam C. Vandervoort, attorney-in-fact
2019-04-09